Resources

Dr. Tamara Hannon talks about the possibility of using rosiglitazone as therapy for children and teens. (Note that this video interview was done before the FDA re-approved rosiglitazone for limited use in adults.) She notes that the drug is more effective with metformin and that some patients simply cannot achieve …

Dr. Tamara Hannon talks about the possibility of using one of the most common adult anti-diabetic medications, sulfonylureas, in children. However, she points out that the drugs can only help adults achieve metabolic control in the short-term which concerns her because children and teens with type 2 diabetes definitely need …

Dr. Tamara Hannon talks about the difficult subject of type 2 diabetes complications for adolescents and the challenges they face with the prospect of a longer life with type 2. She also discusses some of the research that has come out that seems to show the disease progressing faster in …

Dr. Tamara Hannon talks about how she advises her patients and the parents of her patients on physical activity. She explains that the current standards are that children need at least 60 minutes of physical activity every single day but that this standard is being less and less met. She …

Dr. Tamar Hannon explains how she educates her patients about carb counting but that there is a lot of confusion and some of the misinformation seems to be coming directly and deliberately from the food companies themselves so it’s important to read labels extremely carefully.

Dr. Tamara Hannon explains how her type 2 patients make the transition to adult-care physicians. Because type 2 is far more common in adults, endocrinologists and physicians who treat adults are actually more used to treating the disease than pediatricians who rarely see type 2 patients. 

Dr. Tamara Hannon addresses Steve’s questions on the future of type 2 diabetes in children, noting that unless we can begin to make changes as a society, the rates will just keep increasing as the obesity rates just keep going up.

There was a lot of great information at this year’s ADA Scientific Sessions on the sodium glucose co-transporter 2 (SGLT2) inhibitors both alone and in combination with other medications, and we have a review for you. Canagliflozin  Canagliflozin has demonstrated improvement in glycemic control, body weight, and blood pressure across …

FlexTouch® Insulin Analog Pen  FlexTouch® is the first and only prefilled insulin delivery device with no push-button extension and is prefilled with long-acting insulin Levemir® (insulin detemir [rDNA origin] injection). It offers several key features: as 1) Prefilled insulin pens containing 3 mL (300 units) of insulin detemir 2) Doses …

Recent scientific evidence and better tools to monitor for hypoglycemia helped establish the new position statement…. Anne Peters, MD, FACP, professor at the Keck School of Medicine, University of Southern California, said during a press conference at the American Diabetes Association’s 74th Scientific Sessions, “Our goal here is to present …